Answers are grounded in this paper and cite their sources.
Introduction: Antimicrobial resistance (AMR) and healthcare-associated infections (HAIs) are major global health threats. This study investigated the genomic landscape and clonal diversity in a targeted hospital-based dataset using whole-genome sequencing (WGS). Methods: Carbapenemase-producing K. pneumoniae isolates exhibiting resistance or reduced susceptibility to carbapenems, comprising infection isolates and selected rectal surveillance swabs were collected between March 2023 and March 2025. Isolates were subjected to WGS using the Illumina NovaSeq X Plus platform, followed by bioinformatic analyses with Galaxy. Phylogenetic relationships were inferred through core-genome alignment and high-resolution SNP analysis. Results: Within the targeted sequenced dataset, the most frequently detected lineages were ST512 (43.3%) and ST147 (30.0%). Phylogenetic analysis revealed high genomic relatedness and temporal persistence of ST512, whereas ST147 and ST2442 showed greater genetic diversity. Phenotypic resistance exceeded 80% for carbapenems and fluoroquinolones. The resistome was characterized by a high prevalence of blaSHV, blaKPC-3 (73.3%), and blaOXA-9 (66.7%), frequently co-occurring. The blaNDM-1 gene was detected in 20% of sequenced isolates; because NDM-positive surveillance isolates were deliberately enriched, this proportion should not be interpreted as hospital-wide prevalence, mainly within ST2442 and ST5859, indicating increasing enzymatic diversity and a shift from a predominantly KPC-driven epidemiology to a more heterogeneous carbapenemase landscape. Conclusion: Genomically related MDR K. pneumoniae isolates were recovered from several hospital wards; however, genomic relatedness alone does not establish direct transmission routes. The identification of blaNDM-1 alongside blaKPC-3 highlights an evolving, increasingly complex carbapenemase landscape. This study offers a targeted genomic snapshot of selected high-risk clones and emerging resistance determinants, providing actionable data to support institutional infection prevention and control (IPC) protocols and antimicrobial stewardship.
No takes yet. Share an insight, caveat, or question.
Muresu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: